title: Levomilnacipran (Fetzima) for Major Depressive Disorder.
authors.affiliation: University of Virginia Health System, Charlottesville, VA, USA.
authors.forename: Samira
authors.initials: S
authors.lastname: Zaman
authors.affiliation: University of Virginia Health System, Charlottesville, VA, USA.
authors.forename: Maura R
authors.initials: MR
authors.lastname: McLaughlin
mesh_terms: D000328:Adult; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D002319:Cardiovascular System / Q000187:drug effects*; D003521:Cyclopropanes / Q000008:administration & dosage / Q000009:adverse effects; D003865:Major Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D000078764:Milnacipran; D011569:Psychiatric Status Rating Scales; D011580:Psychological Techniques; D020230:Serotonin Syndrome / Q000209:etiology / Q000517:prevention & control*; D059020:Suicidal Ideation; D013405:Suicide / Q000523:psychology; D016896:Treatment Outcome; D000092864:Suicide Prevention
chemical_list: D000928:Antidepressive Agents; D003521:Cyclopropanes; D000078764:Milnacipran